Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-01-26 Purchase | 2024-01-30 7:33 pm | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 40,983 | $0 | $0 | 88,443 (Direct) | View |
2024-01-26 Purchase | 2024-01-30 7:00 pm | RenovoRx Inc. | RNXT | Spiegel Robert J. Director | 40,983 | $0 | $0 | 81,966 (Direct) | View |
2024-01-26 Purchase | 2024-01-30 6:57 pm | RenovoRx Inc. | RNXT | Bagai Shaun Chief Executive Officer | 40,983 | $0 | $0 | 333,523 (Direct) | View |
2024-01-26 Purchase | 2024-01-30 6:32 pm | RenovoRx Inc. | RNXT | Marton Laurence Director | 8,196 | $0 | $0 | 41,830 (Direct) | View |
2024-01-26 Purchase | 2024-01-30 6:30 pm | RenovoRx Inc. | RNXT | Macfarlane K. Angela Director | 40,983 | $0 | $0 | 81,966 (Direct) | View |
2023-10-03 Purchase | 2023-10-04 4:44 pm | RenovoRx Inc. | RNXT | Nelms Angela Chief Operating Officer | 1,100 | $1.0463 | $1,151 | 1,100 (Direct) | View |
2022-06-07 Purchase | 2022-06-09 06:04 am | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer 10% Owner | 5,182 | $1.93 | $10,001 | 981,477 (Indirect Direct) | View |
2022-05-19 Purchase | 2022-05-23 06:09 am | RenovoRx Inc. | RNXT | Bagai Shaun Chief Executive Officer | 5,500 | $2.05 | $11,275 | 251,557 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-10-01 Option Award | 2024-10-02 4:30 pm | N/A 2034-10-01 | RenovoRx Inc. | RNXT | RYAN UNA S Director | 25,099 | $0 | 25,099 (Direct) | View |
2024-10-01 Option Award | 2024-10-02 4:30 pm | N/A 2034-10-01 | RenovoRx Inc. | RNXT | Macfarlane K. Angela Director | 25,099 | $0 | 25,099 (Direct) | View |
2024-10-01 Option Award | 2024-10-02 4:30 pm | N/A 2034-10-01 | RenovoRx Inc. | RNXT | Marton Laurence Director | 25,099 | $0 | 25,099 (Direct) | View |
2024-10-01 Option Award | 2024-10-02 4:30 pm | N/A 2034-10-01 | RenovoRx Inc. | RNXT | Spiegel Robert J. Director | 25,099 | $0 | 25,099 (Direct) | View |
2024-03-06 Option Award | 2024-03-08 4:28 pm | N/A N/A | RenovoRx Inc. | RNXT | Gentry Leesa Chief Clinical Officer | 190,000 | $0 | 190,000 (Direct) | View |
Ownership | 2024-03-08 4:26 pm | 2023-06-01 N/A | RenovoRx Inc. | RNXT | Gentry Leesa Chief Clinical Officer | 0 | $0 | 142,072 (Direct) | View |
2024-02-09 Option Award | 2024-02-12 7:46 pm | N/A N/A | RenovoRx Inc. | RNXT | Kocak Ron VP, Controller and PAO | 15,000 | $0 | 15,000 (Direct) | View |
Ownership | 2024-02-12 7:39 pm | 2022-08-18 N/A | RenovoRx Inc. | RNXT | Kocak Ron VP, Controller and PAO | 0 | $0 | 113,641 (Direct) | View |
2024-01-19 Option Award | 2024-01-23 9:50 pm | N/A N/A | RenovoRx Inc. | RNXT | Nelms Angela Chief Operating Officer | 158,900 | $0 | 158,900 (Direct) | View |
2024-01-19 Option Award | 2024-01-23 9:50 pm | N/A N/A | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 153,556 | $0 | 153,556 (Direct) | View |
2024-01-19 Option Award | 2024-01-23 9:50 pm | N/A N/A | RenovoRx Inc. | RNXT | Bagai Shaun Chief Executive Officer | 317,236 | $0 | 317,236 (Direct) | View |
2023-10-01 Option Award | 2023-10-02 4:15 pm | N/A 2033-10-01 | RenovoRx Inc. | RNXT | Spiegel Robert J. Director | 25,099 | $0 | 25,099 (Direct) | View |
2023-10-01 Option Award | 2023-10-02 4:15 pm | N/A 2033-10-01 | RenovoRx Inc. | RNXT | Marton Laurence Director | 25,099 | $0 | 25,099 (Direct) | View |
2023-10-01 Option Award | 2023-10-02 4:15 pm | N/A 2033-10-01 | RenovoRx Inc. | RNXT | RYAN UNA S Director | 25,099 | $0 | 25,099 (Direct) | View |
2023-10-01 Option Award | 2023-10-02 4:15 pm | N/A 2033-10-01 | RenovoRx Inc. | RNXT | Diamond David Director | 25,099 | $0 | 25,099 (Direct) | View |
2023-10-01 Option Award | 2023-10-02 4:15 pm | N/A 2033-10-01 | RenovoRx Inc. | RNXT | Macfarlane K. Angela Director | 25,099 | $0 | 25,099 (Direct) | View |
2023-04-25 Option Award | 2023-04-27 4:43 pm | N/A 2033-04-25 | RenovoRx Inc. | RNXT | Spiegel Robert J. Director | 43,026 | $0 | 43,026 (Direct) | View |
2023-03-15 Option Award | 2023-03-29 4:57 pm | N/A 2033-03-15 | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 65,000 | $0 | 65,000 (Direct) | View |
2023-03-15 Option Award | 2023-03-29 4:55 pm | N/A 2033-03-15 | RenovoRx Inc. | RNXT | Bagai Shaun CEO | 130,000 | $0 | 130,000 (Direct) | View |
2023-03-15 Option Award | 2023-03-29 4:54 pm | N/A 2033-03-15 | RenovoRx Inc. | RNXT | Nelms Angela Chief Operating Officer | 32,500 | $0 | 32,500 (Direct) | View |
2022-11-03 Exercise | 2022-11-04 4:48 pm | N/A N/A | RenovoRx Inc. | RNXT | Marton Laurence Director | 25,438 | $1.7 | 25,438 (Direct) | View |
2022-11-03 Exercise | 2022-11-04 4:48 pm | N/A 2023-04-02 | RenovoRx Inc. | RNXT | Marton Laurence Director | 25,438 | $0 | 25,438 (Direct) | View |
2022-10-01 Option Award | 2022-10-04 4:44 pm | N/A 2032-10-01 | RenovoRx Inc. | RNXT | RYAN UNA S Director | 25,099 | $0 | 25,099 (Direct) | View |
2022-10-01 Option Award | 2022-10-04 4:36 pm | N/A 2032-10-01 | RenovoRx Inc. | RNXT | Marton Laurence Director | 25,099 | $0 | 25,099 (Direct) | View |
2022-10-01 Option Award | 2022-10-04 4:30 pm | N/A 2032-10-01 | RenovoRx Inc. | RNXT | Macfarlane K. Angela Director | 25,099 | $0 | 25,099 (Direct) | View |
2022-10-01 Option Award | 2022-10-04 4:27 pm | N/A 2032-10-01 | RenovoRx Inc. | RNXT | Diamond David Director | 25,099 | $0 | 25,099 (Direct) | View |
2022-09-19 Option Award | 2022-09-21 4:14 pm | N/A 2032-09-19 | RenovoRx Inc. | RNXT | Nelms Angela Chief Operating Officer | 274,230 | $0 | 274,230 (Direct) | View |
2021-08-30 Conversion | 2022-06-17 4:06 pm | N/A N/A | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer 10% Owner | 2,590 | $0 | 977,590 (Direct) | View |
Ownership(A) | 2022-06-17 4:05 pm | N/A 2022-04-30 | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer 10% Owner | 0 | $0 | 1,295 (Direct) | View |
2022-03-16 Gift | 2022-06-09 06:04 am | N/A N/A | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer 10% Owner | 975,000 | $0 | 981,477 (Direct) | View |
Ownership | 2022-04-14 2:46 pm | N/A N/A | RenovoRx Inc. | RNXT | BANK OF THE WEST 10% Owner | 0 | $0 | 975,000 (Indirect) | View |